21 June 2023, Royal College of Physicians, London (UK) This year we have high profile speakers presenting how precision medicine is being used in various diseases, and how pharmacogenetics is being implemented in the clinic to improve healthcare in the UK. The meeting will be chaired by Professor Sir Munir Pirmohamed. #UKPGx2023 – For more […]
PV Resources
Declaration of Helsinki
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
European Medicines Agency. Good pharmacovigilance practices (GVP Modules I to XVI)
European Medicines Agency. Good pharmacovigilance practices (GVP Modules I to XVI)
The Observational Medical Outcomes Partnership
The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership designed to protect human health by improving the monitoring of drugs for safety and effectiveness. The partnership will conduct a two-year initiative to research methods that are feasible and useful to analyze existing healthcare databases to identify and evaluate safety issues of drugs already on […]
BMA report about pharmacovigilance
Report: pdf file
EudraVigilance Expert Working Group’s (EV-EWG’s)
The EudraVigilance Expert Working Group (EV-EWG) has coordinated the development of an Important Medical Event Terms (IME) list. This IME list aims to facilitate the classification of suspected adverse reactions as well as aggregated data analysis and case assessment in the frame of the day to day pharmacovigilance activities of stakeholders in the EU. The […]
